Product Information
SPIRONOLACTONE 25 MG/5 ML SUSP is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $1.6192 per ML under NDC 69238202708. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Sep 5, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Spironolactone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25 mg/5mL
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238202708
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SPIRONOLACTONEApproval Type
Generic (ANDA)
FDA Application
ANDA215572FDA Approved
9/5/2023
TE Code
AB
On Market Since
9/8/2023
Pharmacological Classes
Price Statistics
The NADAC for SPIRONOLACTONE 25 MG/5 ML SUSP has been published 129 times since Apr 17, 2024, and over the history we have for it it has declined 45.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6192 per ML |
|---|---|
| All-time high | $2.9671 (May 15, 2024) |
| All-time low | $1.5315 (Jul 22, 2026) |
| 52-week high | $2.1173 |
| 52-week low | $1.5315 |
| Median price | $2.0401 |
| Average price | $2.0408 |
| Largest weekly change | -15.6% (Jul 17, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals NY LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Spironolactone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aldosterone Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SPIRONOLACTONE 25 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for SPIRONOLACTONE 25 MG/5 ML SUSP, manufactured by Amneal Pharmaceuticals NY LLC, is $1.6192 per ML (NDC 69238202708), effective Sep 30, 2026.
How has the price of SPIRONOLACTONE 25 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for SPIRONOLACTONE 25 MG/5 ML SUSP has declined 45.4%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for SPIRONOLACTONE 25 MG/5 ML SUSP?
Since Apr 17, 2024, the NADAC for SPIRONOLACTONE 25 MG/5 ML SUSP has ranged from a low of $1.5315 (Jul 22, 2026) to a high of $2.9671 (May 15, 2024), with a median of $2.0401 per ML.
Are there cheaper alternatives to SPIRONOLACTONE 25 MG/5 ML SUSP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SPIRONOLACTONE 25 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures SPIRONOLACTONE 25 MG/5 ML SUSP?
SPIRONOLACTONE 25 MG/5 ML SUSP (NDC 69238202708) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.